This research found evidence supporting noninferiority of ramosetron compared to ondansetron for the treatment of established PONV in moderate to high-risk patients undergoing laparoscopic surgery https://t.co/uYVlVJpDbU
This research found evidence supporting noninferiority of ramosetron compared to ondansetron for the treatment of established PONV in moderate to high-risk patients undergoing laparoscopic surgery https://t.co/1hzNz0NwIL
This research found evidence supporting noninferiority of ramosetron compared to ondansetron for the treatment of established PONV in moderate to high-risk patients undergoing laparoscopic surgery https://t.co/UED8Gud8fg
Comparison of ramosetron and ondansetron for the treatment of establis | TCRM https://t.co/LShuqaT7q4